Cyfuse Biomedical K.K. 4892Short Interest
No institution currently reports a short position of 0.5% or more in Cyfuse Biomedical K.K. (4892). The last disclosure was on 2026-08-17 (UBS AG, 0.49%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
1357 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 2 institutions whose last report is more than a year old (1.80% in total). It also excludes 11 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2022-12-07 |
|---|---|
| Latest disclosure | 2026-08-17 (UBS AG, 0.49%) |
| Reporting institutions | 13 firms (1357 reports) |
| Peak estimated short interest | 18.49% (2023-08-03, 8 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Morgan Stanley MUFG Securities Co., Ltd.
- GOLDMAN SACHS INTERNATIONAL
- UBS AG
- JPM Securities Japan Co Ltd.
- Barclays Capital Securities Ltd
- Others
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2023-12-06 | BNP Paribas Arbitrage SNC | Position 75,400 shares | Ratio 0.96% | ▼0.13% | No report for 1+ year |
| 2023-12-11 | BNP Paribas Financial Markets formerly known as BNP Paribas Arbitrage SNC | Position 66,200 shares | Ratio 0.84% | ▼0.12% | No report for 1+ year |
| 2026-08-17 | UBS AG | Position 49,600 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-07-17 | Barclays Capital Securities Ltd | Position 49,500 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2023-12-19 | BNP Paribas Financial Markets SNC formerly known as BNP Paribas Arbitrage SNC | Position 39,000 shares | Ratio 0.49% | ▼0.10% | Below 0.5% |
| 2025-03-05 | Pi Radians Capital Inc. | Position 40,200 shares | Ratio 0.49% | ▼0.04% | Below 0.5% |
| 2025-05-16 | BNP Paribas Financial Markets SNC | Position 41,500 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2025-04-04 | Citigroup Global Markets Limited | Position 39,800 shares | Ratio 0.48% | ▼0.03% | Below 0.5% |
| 2025-06-10 | MERRILL LYNCH INTERNATIONAL | Position 39,700 shares | Ratio 0.47% | ▼0.03% | Below 0.5% |
| 2025-08-26 | JPM Securities Japan Co Ltd. | Position 43,500 shares | Ratio 0.47% | ▼0.12% | Below 0.5% |
| 2026-06-08 | GOLDMAN SACHS INTERNATIONAL | Position 47,100 shares | Ratio 0.46% | ▼0.13% | Below 0.5% |
| 2026-06-18 | Nomura International plc | Position 45,300 shares | Ratio 0.44% | ▼0.10% | Below 0.5% |
| 2025-12-26 | Morgan Stanley MUFG Securities Co., Ltd. | Position 35,400 shares | Ratio 0.36% | ▼0.14% | Below 0.5% |
Disclosure History 1357 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-08-17 | UBS AG | Position 49,600 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-07-21 | UBS AG | Position 51,200 shares | Ratio 0.50% | ▲0.01% | — |
| 2026-07-17 | Barclays Capital Securities Ltd | Position 49,500 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2026-07-16 | Barclays Capital Securities Ltd | Position 51,500 shares | Ratio 0.51% | ▲0.02% | — |
| 2026-07-08 | Barclays Capital Securities Ltd | Position 50,300 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-07-07 | Barclays Capital Securities Ltd | Position 50,900 shares | Ratio 0.50% | ▲0.03% | — |
| 2026-07-02 | Barclays Capital Securities Ltd | Position 47,600 shares | Ratio 0.47% | ▼0.03% | Below 0.5% |
| 2026-06-24 | UBS AG | Position 50,300 shares | Ratio 0.49% | ▼0.09% | Below 0.5% |
| 2026-06-24 | Barclays Capital Securities Ltd | Position 50,600 shares | Ratio 0.50% | ▲0.03% | — |
| 2026-06-22 | Barclays Capital Securities Ltd | Position 48,300 shares | Ratio 0.47% | ▼0.05% | Below 0.5% |
| 2026-06-19 | Barclays Capital Securities Ltd | Position 52,500 shares | Ratio 0.52% | ▲0.10% | — |
| 2026-06-18 | Nomura International plc | Position 45,300 shares | Ratio 0.44% | ▼0.10% | Below 0.5% |
| 2026-06-12 | Nomura International plc | Position 54,700 shares | Ratio 0.54% | ▼0.06% | — |
| 2026-06-09 | UBS AG | Position 58,800 shares | Ratio 0.58% | ▼0.02% | — |
| 2026-06-08 | Nomura International plc | Position 60,600 shares | Ratio 0.60% | ▲0.11% | — |
| 2026-06-08 | GOLDMAN SACHS INTERNATIONAL | Position 47,100 shares | Ratio 0.46% | ▼0.13% | Below 0.5% |
| 2026-06-05 | UBS AG | Position 60,600 shares | Ratio 0.60% | ▲0.01% | — |
| 2026-06-05 | Nomura International plc | Position 49,566 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2026-06-04 | UBS AG | Position 60,500 shares | Ratio 0.59% | ▼0.01% | — |
| 2026-06-03 | UBS AG | Position 60,800 shares | Ratio 0.60% | ▲0.03% | — |
| 2026-06-03 | Nomura International plc | Position 51,600 shares | Ratio 0.51% | ▼0.14% | — |
| 2026-06-02 | Nomura International plc | Position 65,865 shares | Ratio 0.65% | ▲0.09% | — |
| 2026-05-29 | Nomura International plc | Position 56,800 shares | Ratio 0.56% | ▼0.07% | — |
| 2026-05-28 | Nomura International plc | Position 63,600 shares | Ratio 0.63% | ▲0.05% | — |
| 2026-05-26 | Nomura International plc | Position 58,700 shares | Ratio 0.58% | ▲0.11% | — |
| 2026-05-26 | GOLDMAN SACHS INTERNATIONAL | Position 60,000 shares | Ratio 0.59% | ▼0.07% | — |
| 2026-05-21 | Nomura International plc | Position 47,400 shares | Ratio 0.46% | ▼0.13% | Below 0.5% |
| 2026-05-20 | UBS AG | Position 58,100 shares | Ratio 0.57% | ▲0.16% | — |
| 2026-05-20 | Nomura International plc | Position 60,000 shares | Ratio 0.59% | ▲0.20% | — |
| 2026-05-18 | Nomura International plc | Position 46,200 shares | Ratio 0.45% | ▼0.06% | Below 0.5% |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| SAWAI GROUP HOLDINGS Co.,Ltd.4887 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| STELLA PHARMA CORPORATION4888 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Renascience Inc.4889 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Tsubota Laboratory Incorporated4890 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| TMS Co.,Ltd.4891 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Noile-Immune Biotech Inc.4893 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Cuorips Inc.4894 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| K Pharma,Inc.4896 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Innovacell Inc.504A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| J-Pharma Co.,Ltd.520A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |